Fév 26, 2024
Please fill out this simple form to receive the publication. Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos- Publication in Leukemia (Springer Nature). We are pleased to communicate our new study on Follicular... 
Jan 26, 2023
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies We are delighted to share the publication of our preclinical Melanoma AVI-PDXTM model. Our study was conducted with the Hospices Civils de Lyon, the Cancer Research Center of Lyon... 
Jan 20, 2023
Download the press release This strategic acquisition expands ERBC Group’s non-clinical research and development testing portfolio, adding in ovo models for anticancer drug development. Baugy, France, January 18th 2023 – ERBC Group, a non-clinical contract research... 
Jan 27, 2022
We are delighted to present the publication reporting our AVI-PDM™ model of breast cancers, and preclinical studies using our in vivo model conducted in collaboration with Erytech Pharma. Download the... 
Jan 27, 2022
We are delighted to announce that the US patent office granted a patent for the technology of implantation of human tumoral cells within tissues of the avian embryo to create tumoral models representative of patient diseases. This in vivo process is at the core of the... 
Fév 17, 2021
February 2021, Astrazeneca, The Carnot Calym Institute and Inserm Transfert for Inserm sign a framework agreement for research collaboration in lymphomas. Within three months of the agreement, two projects have already been lauched : INOVO and INTREPIDS. The INOVO... 
Commentaires récents